Skip to main content
Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · IEX Real-Time Price · USD
1.060
0.00 (0.00%)
At close: Jul 26, 2024, 4:00 PM
1.030
-0.030 (-2.83%)
After-hours: Jul 26, 2024, 4:44 PM EDT

Ovid Therapeutics Revenue

Ovid Therapeutics had revenue of $148.00K in the quarter ending March 31, 2024, with 124.24% growth. This brings the company's revenue in the last twelve months to $473.70K, up 283.93% year-over-year. In the year 2023, Ovid Therapeutics had annual revenue of $391.70K, down -73.93%.

Revenue (ttm)
$473.70K
Revenue Growth
+283.93%
P/S Ratio
158.81
Revenue / Employee
$11,838
Employees
40
Market Cap
75.20M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023391.70K-1.11M-73.93%
Dec 31, 20221.50M-206.88M-99.28%
Dec 31, 2021208.38M195.77M1,551.57%
Dec 31, 202012.62M--
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Eagle Pharmaceuticals 257.55M
Spero Therapeutics 110.98M
Theratechnologies 60.71M
SHL Telemedicine 57.08M
Gritstone bio 15.65M
Genelux 8.00K
Revenue Rankings

OVID News

More News